Recently, the pharma industry has been getting alot of positive press. I believe that in part, the rise may be due to realization that outsourcing will continue. Pharma consolidation, while not over, appears to have subsided and companies are now moving forward with rationalized pipelines, yet need help.
I am seeing some improvement in the industry and positive press in the applicable trade journals supports this. Up 5% today on double normal volume is a good sign. There has been some small volume in November, calls mostly, I think this might be a factor, but small.